Lataa...

Effects of chronic administration of the novel endothelin antagonist J-104132 on endothelial dysfunction in streptozotocin-induced diabetic rat

1. The biosynthesis of endothelin-1 is increased in the diabetic state. So this peptide may cause diabetic vascular complications. We tested this possibility by chronically administering J-104132, a potent orally active mixed antagonist of endothelin A and B (ET(A)/ET(B)) receptors to streptozotocin...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Kanie, Noriyasu, Kamata, Katsuo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2002
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1573322/
https://ncbi.nlm.nih.gov/pubmed/11959796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0704659
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!